Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: <i>In Silico</i> and <i>In Vitro</i> Studies-Reference-Cited by-同舟云学术

Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies

Published:2022-10-24 Issue:6 Volume:2 Page:565-585
ISSN:2694-2437
Container-title:ACS Bio & Med Chem Au
language:en
Short-container-title:ACS Bio Med Chem Au

Author:

Rabie Amgad M.¹²^ORCID,Abdalla Mohnad³^ORCID

Affiliation:

1. Dr. Amgad Rabie’s Research Lab. for Drug Discovery (DARLD), Mansoura City35511,Mansoura, Dakahlia Governorate, Egypt

2. Head of Drug Discovery & Clinical Research Department, Dikernis General Hospital (DGH), Magliss El-Madina Street, Dikernis City35744,Dikernis, Dakahlia Governorate, Egypt

3. Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Jinan, Shandong Province250012, P. R. China

Publisher

American Chemical Society (ACS)

Subject

Pharmaceutical Science,Drug Discovery,Molecular Biology,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.2c00039

Reference39 articles.

1. A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

2. The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro

3. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review

4. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19

5. Cyanorona-20: The first potent anti-SARS-CoV-2 agent

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the DNA-Binding and Anticancer Potential of Polypyridyl Ruthenium(II) Complexes;Journal of Molecular Structure;2024-09

2. The Isoquinoline Derivative "CYNOVID" as a Prospective Anti-SARS-CoV-2 Agent: An Expanded Investigative Computational Study;European Journal of Medicinal Chemistry Reports;2024-09

3. Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study;Expert Review of Anti-infective Therapy;2024-06-27

4. Effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trial;F1000Research;2024-06-11

5. Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases;Expert Review of Anti-infective Therapy;2024-05-08